Delivery Order SPE2DB25D3202-SPE2DB25FTBJV
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Irbesartan 75 mg tablets (quantity 90) with a ceiling value of $1,558.90. The award was made on August 26, 2025, with an ultimate completion date of August 27, 2025, under a firm fixed-price contract type with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and performed the work at its corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Irbesartan 75 mg tablets in a quantity of 90 units, with a ceiling value of $5,990.86. This contract, classified as a firm fixed price delivery order with no set-aside designation, represents a competitively awarded procurement under AmerisourceBergen's existing indefinite delivery contract (IDC) with DLA Troop Support Medical. The pharmaceutical product will be delivered to...
- The Defense Logistics Agency awarded a $1,357.37 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Irbesartan 75 mg tablets in quantities of 90 units. The contract was awarded on September 11, 2025, with an ultimate completion date of September 12, 2025, and represents a non-set-aside competitive award. Performance will occur at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Irbesartan 150 mg tablets in quantities of 90 units, with a contract ceiling value of $2,260.39. This firm fixed-price delivery order, which is set to be completed by August 15, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contract was competitively awarded with no set-aside...
- The Defense Logistics Agency (DLA) awarded a $5,160.85 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 90 tablets of Irbesartan 150 mg on August 11, 2025, with completion due by August 12, 2025. This contract was competitively awarded with no set-aside designation and is performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement, serves as...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at approximately $26,000 to Amerisourcebergen Drug Corporation. Under the contract, Amerisourcebergen will provide 150mg tablets of Irbesartan, totaling 90 tablets, to support the Department of Defense's medical supply needs. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one-day period in late August 2023. As the prime contractor, Amerisourcebergen Drug Corporation will...
- The Defense Logistics Agency awarded a delivery order valued at $362,880 to Amerisourcebergen Drug Corporation for the provision of 150 mg Irbesartan tablets. The firm fixed price order calls for the delivery of 90 count bottles of the hypertension medication to a facility in Conshohocken, Pennsylvania, with performance required between July 24-25, 2023. As a leading provider of pharmaceuticals and medical supplies to the Department of Defense, Amerisourcebergen will fulfill this order in...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,152.65 Firm Fixed Price Delivery Order contract is for the supply of Irbesartan 300 mg tablets, a medication used to treat high blood pressure. The contract has an ultimate completion date of March 14, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award, valued at $2,202.90, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Irbesartan 300 mg Tablets in 90-count packages, with a completion date of April 28, 2025. The contract is a Firm Fixed Price Delivery Order, and there is no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant...
- This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,867.88, is for the delivery of Irbesartan 150 mg tablets. It is a firm fixed-price contract with an ultimate completion date of May 6, 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical...
- SPE2DB25D3202Indefinite Delivery Contract
- SPE2DB25D3202-SPE2DB25FTBJVDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,035.92 to AmerisourceBergen Drug Corp for Irbesartan 75 mg tablets (90-count) on September 16, 2025, with completion anticipated by September 17, 2025. This competitively awarded, firm fixed-price contract represents a non-set-aside procurement of a generic antihypertensive medication to support federal healthcare operations. The contract is performed at the contractor's facility in Conshohocken, Pennsylvania, the company's corporate headquarters. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999,999,999.00 prime vehicle extending through December 2026 that serves as a comprehensive global pharmaceutical support platform. The IDC enables the contractor to supply a broad range of brand-name and generic medications, vaccines, and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard. AmerisourceBergen's extensive experience fulfilling federal pharmaceutical procurement requirements and demonstrated capability across multiple therapeutic domains through open competition positions it as a critical vendor within the military medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 9/16/25 |